Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...

With the planned purchase, Boston Scientific will gain a portfolio of devices to remove clots from blood vessels.

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal. Penumbra is focused on developing technologies for challenging medical conditions such as ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Analysis from a Columbia and Rutgers Health team finds long-term antipsychotic use rose 65% from 2015 to 2024.

Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock ...